Timing of glycoprotein IIb/IIIa inhibitor use and outcomes among patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention (results from CRUSADE).

Timing of glycoprotein IIb/IIIa inhibitor use and outcomes among patients with non-ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention (results from CRUSADE). Am J Cardiol. 2007 May 15; 99(10):1389-93.

View in: PubMed

subject areas

Aged
Angina, Unstable
Angioplasty, Balloon, Coronary
Antibodies, Monoclonal
Combined Modality Therapy
Female
Hospital Mortality
Humans
Immunoglobulin Fab Fragments
Male
Middle Aged
Myocardial Infarction
Peptides
Platelet Aggregation Inhibitors
Platelet Glycoprotein GPIIb-IIIa Complex
Time Factors
Treatment Outcome
Tyrosine
United States

authors with profiles

Robert Harrington